Drugs / Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02428309 | Aug 2015 → Sep 2016 | discoid lupus erythematosus, systemic lupus erythematosus | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02428309 ↗ |